Anti-hepatitis B virus surface antigen titers after a vaccination program in children and adolescents. Should a booster dose be given?;Títulos de anti-HBs tras un programa de vacunación en niños y adolescentes: ¿Revacunar?

Anales Espanoles de Pediatria

Volumn 54, Issue 1, 2001, Pages 32-37

  Garcia Llop L A ^a   Asensi Alcoverroa, A ^a   Coll Mas P ^a   Ramada Benedito, Ma A ^a   Grafia Juan C ^a  

^a NONE   (Spain)

Author keywords

Adolescent; Antigen; Dose; Hepatitis B vaccine; Immunization; Immunologic memory; Schedule

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ADOLESCENT; ADOLESCENT DISEASE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; DRUG EFFICACY; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; PASSIVE IMMUNIZATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; INFANT; INFANT, NEWBORN;

EID: 0035745564     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Prevention of acute and chronic liver disease through immunization: Hepatitis B and beyond
2. Vaccines to prevent viral hepatitis
3. Thimerosal in vaccines
4. Demonstration of the interchangeability of 2 types of recombinant anti-hepatitis B vaccine
5. Comité Asesor de Vacunas de la AEP
6. A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B
7. Long-term efficacy of plasma-derived hepatitis B vaccine: A 15 year follow-up study among Chinese children
8. Twelve-year follow-up of a prospective randomized trail of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster closes in children
9. Protection provided by hepatitis B vaccine in a Yupik Eskimo population: Results of a 10 year study
10. Hepatitis B in high-risk infants: 10 Year follow-up
11. Evaluation of the effectiveness nine years after primary immunization with local produced plasma-derived hepatitis B vaccine
12. Nine-year follow-up study a plasma-derived hepatitis B vaccine in a rural African setting
13. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis b vaccination programme
14. Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan
15. Five-year follow-up of vaccination against hepatitis B virus in newborns vaccinated with a reduced number of doses
16. Increases in levels of antibody to hepatitis B surface antigen in an immunized population
17. Impact of rutine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy
18. Duration of immune response to hepatitis B vaccine in high-risk Chinesse adolescents
19. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants
20. Eficacia a largo plazo de la vacuna recombinante de hepatitis B en recién nacidos
21. Follow-up on hepatitis B immunized neonates born to HBsAg positive mothers
22. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: Protective efficacy and long-term immunogenicity
23. The need for more aggressive folow-up of children born to hepatitis B surface antigen-positive mother: Lessons from the Louisiana Perinatal Hepatitis B Immunization Program
24. A 9-year fllow-up study of the immunogenecity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinesse neonates
25. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen
26. Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans
27. Humoral and cellular immune resposes to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen
28. Serologic hepatitis B immunity in vaccinated health care workers
29. High rate of seroconversion following administration of a single suppleementary dose of recombinant hepatitis B vaccine in Iranian healthy nonresponder
30. Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: Follow-up at 5 years
31. Booster vaccination with recombinant hepatitis B vaccine four years after priming with on single dose
32. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen
33. Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine
34. Vaccine induced immunologic memory for hepatitis B surface antigen: Implications for policy on booster vaccination
35. Are booster immunisations needed for lifelong hepatitis B immunity?
36. El Título de anticuerpos, la memoria inmunológica y la eficacia protectora de la vacuna frente a Haemofilus influenzae tipo b
37. Hepatitis B vaccine administered to children and adolescents at yearly intervals